Glen Burkhardt serves as Executive at PhaseBio Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, Glen Burkhardt has executed 8 insider transactions totaling $47.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on May 23, 2022 involved selling 11,248 shares valued at $8.9K.
Glen Burkhardt currently holds 11,248 shares of PhaseBio Pharmaceuticals Inc (PHAS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Glen Burkhardt has been a net seller of PHAS stock. They have purchased $0 and sold $47.2K worth of shares.
Glen Burkhardt's most recent insider trade was on May 23, 2022, when they sold 11,248 shares at $0.79 per share.
Get notified when new Form 4 filings are submitted
| $0.68 |
| Discretionary |
| Nov 19, 2021 | PHAS | $11.6K | Award | 5,766 | $2.01 | Discretionary |
| Nov 19, 2021 | PHAS | $13.7K | Sale | 5,766 | $2.37 | Discretionary |
| May 20, 2021 | PHAS | $12.5K | Sale | 3,811 | $3.29 | Discretionary |
| May 20, 2021 | PHAS | $10.7K | Award | 3,811 | $2.80 | Discretionary |
| Nov 23, 2020 | PHAS | $12.1K | Sale | 3,497 | $3.45 | Discretionary |
| Nov 20, 2020 | PHAS | $10.5K | Award | 3,497 | $3.00 | Discretionary |